V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005856 | 220011269 | null | null | Palliative (P) | 2015-02-25 | 2015-02-25 | Nilotinib | null | Y | 220029112 | NILOTINIB |
| 220005857 | 220002285 | 1.75 | 61.5 | Curative (C) | null | 2017-06-27 | FLAG + Idarubicin | N | N | 220029118 | FLAG + IDARUBICIN |
| 220005858 | 220002285 | 1.73 | 75 | null | 2013-10-04 | 2013-10-04 | FLAG + Idarubicin | Y | N | 220029118 | FLAG + IDARUBICIN |
| 220005859 | 220002286 | 1.69 | 98.2 | null | 2014-03-09 | 2014-03-12 | FLAG + Idarubicin | 2 | N | 220029122 | FLAG + IDARUBICIN |
| 220005860 | 220002286 | 1.7 | 79.2 | Curative (C) | 2015-05-18 | 2015-05-21 | AML 19 TRIAL | N | N | 220029122 | AML19 TRIAL |
| 220005861 | 220002286 | 1.68 | 69.8 | Curative (C) | 2016-11-21 | 2016-11-22 | AML 19 TRIAL | null | null | 220029122 | AML19 TRIAL |
| 220005862 | 220002286 | 1.68 | 80.3 | Curative (C) | 2016-10-28 | 2016-10-28 | AML 19 TRIAL | Y | null | 220029122 | AML19 TRIAL |
| 220005863 | 220002287 | 1.75 | null | Curative (C) | 2013-05-19 | 2013-05-19 | FLAG + Idarubicin | N | N | 220029130 | FLAG + IDARUBICIN |
| 220005864 | 220002287 | 1.74 | null | null | null | 2014-11-12 | FLAG + Idarubicin | 2 | N | 220029130 | FLAG + IDARUBICIN |
| 220005865 | 220002288 | 1.74 | 43.3 | Curative (C) | 2013-12-20 | 2013-12-27 | FLAG + Idarubicin | null | N | 220029133 | FLAG + IDARUBICIN |
| 220005866 | 220002288 | 0 | 0 | Curative (C) | 2015-08-22 | 2015-08-23 | Nilotinib | 02 | Y | 220029133 | NILOTINIB |
| 220005867 | 220002288 | 1.63 | 95.2 | Curative (C) | 2013-06-13 | 2013-06-13 | FLAG + Idarubicin | N | N | 220029133 | FLAG + IDARUBICIN |
| 220005868 | 220002289 | null | null | Palliative (P) | 2016-07-29 | 2016-07-29 | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + VINCRISTINE | 1 | N | 220029142 | NOT MATCHED |
| 220005869 | 220002290 | 1.78 | null | Curative (C) | 2017-11-26 | 2017-11-29 | Nilotinib | N | N | 220029144 | NILOTINIB |
| 220005870 | 220002290 | 1.65 | 81 | Curative (C) | 2013-03-15 | 2013-03-15 | AML 19 TRIAL | N | N | 220029144 | AML19 TRIAL |
| 220005871 | 220002290 | 1.57 | 56 | Curative (C) | 2013-09-15 | 2013-09-18 | AML 19 TRIAL | null | N | 220029144 | AML19 TRIAL |
| 220005872 | 220002290 | 1.77 | 72.1 | Disease modification (D) | null | 2016-02-07 | AML 19 TRIAL | Y | N | 220029144 | AML19 TRIAL |
| 220005873 | 220002290 | 1.58 | 88 | Curative (C) | 2016-02-07 | 2016-02-07 | AML 19 TRIAL | 1 | N | 220029144 | AML19 TRIAL |
| 220005874 | 220002291 | 0 | null | null | 2016-11-10 | 2016-11-11 | Nilotinib | N | N | 220029152 | NILOTINIB |
| 220005875 | 220011275 | 1.59 | 104.2 | Curative (C) | 2017-10-02 | 2017-10-02 | AML 19 TRIAL | 01 | null | 220029155 | AML19 TRIAL |
| 220005876 | 220002292 | 1.8 | null | Adjuvant (A) | 2017-02-16 | 2017-02-18 | AML Interim Guidelines FLA -Ida | N | N | 220029162 | NOT MATCHED |
| 220005877 | 220011276 | 1.6 | 96.2 | null | 2016-11-12 | 2016-11-16 | Nilotinib | N | N | 220029163 | NILOTINIB |
| 220005878 | 220002293 | 1.75 | 77.8 | Curative (C) | 2013-07-10 | 2013-07-11 | AML 19 TRIAL | Y | N | 220029166 | AML19 TRIAL |
| 220005882 | 220002295 | 1.72 | 87.8 | Curative (C) | 2013-06-06 | 2013-06-06 | FLAG + Idarubicin | null | N | 220029174 | FLAG + IDARUBICIN |
| 220005883 | 220002295 | 0 | null | Disease modification (D) | 2015-03-25 | 2015-03-25 | Nilotinib | N | N | 220029174 | NILOTINIB |
| 220005884 | 220002295 | 1.64 | 79.8 | Curative (C) | 2015-05-17 | 2015-05-17 | AML 19 TRIAL | 01 | Y | 220029174 | AML19 TRIAL |
| 220005885 | 220002296 | 0 | null | Curative (C) | 2017-10-20 | 2017-11-21 | AML Interim Guidelines | N | N | 220029177 | NOT MATCHED |
| 220005886 | 220002296 | 1.66 | 75.7 | Curative (C) | null | 2014-06-11 | AML 19 TRIAL | Y | null | 220029177 | AML19 TRIAL |
| 220005887 | 220016048 | null | null | Curative (C) | 2016-05-22 | 2016-05-23 | Nilotinib | N | N | 220029179 | NILOTINIB |
| 220005888 | 220018783 | 1.67 | 78 | Curative (C) | 2017-04-10 | 2017-04-12 | AML 19 TRIAL | 01 | N | 220029181 | AML19 TRIAL |
| 220005889 | 220018783 | 1.65 | 77.7 | Curative (C) | 2015-11-27 | 2015-11-27 | AML 19 TRIAL | 01 | N | 220029181 | AML19 TRIAL |
| 220005890 | 220018783 | 1.76 | 67 | Curative (C) | 2015-05-15 | 2015-06-04 | FLAG + Idarubicin | N | N | 220029181 | FLAG + IDARUBICIN |
| 220005891 | 220018783 | 1.6 | 60.6 | Curative (C) | 2015-03-17 | 2015-03-17 | AML 19 TRIAL | 01 | N | 220029181 | AML19 TRIAL |
| 220005892 | 220018783 | 1.82 | 75.2 | Curative (C) | 2015-12-23 | 2015-12-28 | AML 19 TRIAL | 01 | Y | 220029181 | AML19 TRIAL |
| 220005893 | 220018783 | 1.85 | 72.5 | Disease modification (D) | 2014-08-02 | 2014-08-02 | Nilotinib | N | N | 220029181 | NILOTINIB |
| 220005894 | 220018783 | 1.85 | 0 | Disease modification (D) | 2014-08-07 | 2014-08-07 | Nilotinib | 2 | N | 220029181 | NILOTINIB |
| 220005895 | 220018783 | 1.78 | 15.8 | Curative (C) | 2014-06-08 | 2017-05-10 | BMT Fludarabine/Thiotepa/Treosulfan + ATG | null | N | 220029181 | NOT MATCHED |
| 220005896 | 220018783 | 1.78 | 82.75 | Curative (C) | 2013-12-25 | 2013-12-26 | AML 19 TRIAL | null | N | 220029181 | AML19 TRIAL |
| 220005897 | 220018783 | null | 75.9 | Palliative (P) | 2013-08-24 | 2013-08-24 | FLAG + Idarubicin | 2 | N | 220029181 | FLAG + IDARUBICIN |
| 220005898 | 220018783 | 1.69 | 71 | Curative (C) | 2013-05-24 | 2013-05-28 | AML 19 TRIAL | 1 | N | 220029181 | AML19 TRIAL |
| 220005899 | 220002297 | 1.82 | 63.5 | Curative (C) | 2017-02-21 | 2017-02-21 | AML 19 TRIAL | 1 | null | 220029205 | AML19 TRIAL |
| 220005900 | 220002297 | 1.6 | 85.2 | Curative (C) | 2016-08-30 | 2016-08-31 | AML 19 TRIAL | Y | N | 220029205 | AML19 TRIAL |
| 220005901 | 220002297 | 1.79 | null | Curative (C) | 2015-09-13 | 2015-09-14 | AML Interim Guidelines FLAG-Ida | null | null | 220029205 | FLAG + IDARUBICIN |
| 220005902 | 220002298 | null | 67.56 | Curative (C) | 2015-07-10 | 2015-07-14 | AML 19 TRIAL | 01 | N | 220029214 | AML19 TRIAL |
| 220005903 | 220002299 | 1.67 | null | Disease modification (D) | 2017-05-04 | 2017-05-09 | Nilotinib | N | N | 220029219 | NILOTINIB |
| 220005904 | 220002299 | 1.91 | 72 | Curative (C) | null | 2015-09-28 | AML 19 TRIAL | Y | null | 220029219 | AML19 TRIAL |
| 220005905 | 220002300 | 1.78 | 0 | null | 2013-05-22 | 2013-05-22 | Nilotinib | N | N | 220029222 | NILOTINIB |
| 220005906 | 220002301 | 1.74 | 63.1 | Curative (C) | 2014-04-08 | 2014-04-08 | AML 19 TRIAL | Y | N | 220029224 | AML19 TRIAL |
| 220005907 | 220002302 | 0 | null | Not known (9) | 2014-09-13 | 2014-09-14 | Nilotinib | N | N | 220029227 | NILOTINIB |
| 220005908 | 220002302 | 1.68 | 6 | Curative (C) | 2016-06-02 | 2016-06-03 | FLAG + Idarubicin | 2 | N | 220029227 | FLAG + IDARUBICIN |